ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed cash
Cash and short-term investments held at the end of each period.
ResMed's cash was $1.47B at Jun 30, 2026. For fiscal 2026 it was $1.47B, up 21.5% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $1.47B in fiscal 2026.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $1.47B | +21.5% |
| FY2025 | Jun 30, 2025 | $1.21B | +407.4% |
| FY2024 | Jun 30, 2024 | $238.36M | +4.6% |
| FY2023 | Jun 30, 2023 | $227.89M | -16.7% |
| FY2022 | Jun 30, 2022 | $273.71M | -7.3% |
| FY2021 | Jun 30, 2021 | $295.28M | -36.2% |
| FY2020 | Jun 30, 2020 | $463.16M | +214.8% |
| FY2019 | Jun 30, 2019 | $147.13M | -22.0% |
| FY2018 | Jun 30, 2018 | $188.70M | -77.0% |
| FY2017 | Jun 30, 2017 | $821.94M | +12.4% |
| FY2016 | Jun 30, 2016 | $731.43M | +2.0% |
| FY2015 | Jun 30, 2015 | $717.25M | -20.8% |
| FY2014 | Jun 30, 2014 | $905.73M | +3.4% |
| FY2013 | Jun 30, 2013 | $876.05M | +8.2% |
| FY2012 | Jun 30, 2012 | $809.54M | +10.1% |
| FY2011 | Jun 30, 2011 | $735.27M | +50.4% |
| FY2010 | Jun 30, 2010 | $488.78M | +17.6% |
| FY2009 | Jun 30, 2009 | $415.65M | +29.5% |
| FY2008 | Jun 30, 2008 | $321.08M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Jun 30, 2026 | $1.47B | +21.5% |
| Q3 FY2026 | Mar 31, 2026 | $1.66B | +78.0% |
| Q2 FY2026 | Dec 31, 2025 | $1.42B | +171.5% |
| Q1 FY2026 | Sep 30, 2025 | $1.38B | +224.6% |
| Q4 FY2025 | Jun 30, 2025 | $1.21B | +407.4% |
| Q3 FY2025 | Mar 31, 2025 | $932.71M | +292.0% |
| Q2 FY2025 | Dec 31, 2024 | $521.94M | +148.3% |
| Q1 FY2025 | Sep 30, 2024 | $426.36M | +103.9% |
| Q4 FY2024 | Jun 30, 2024 | $238.36M | +4.6% |
| Q3 FY2024 | Mar 31, 2024 | $237.91M | +4.4% |
| Q2 FY2024 | Dec 31, 2023 | $210.25M | -17.0% |
| Q1 FY2024 | Sep 30, 2023 | $209.10M | +0.9% |
| Q4 FY2023 | Jun 30, 2023 | $227.89M | -16.7% |
| Q3 FY2023 | Mar 31, 2023 | $227.89M | +12.9% |
| Q2 FY2023 | Dec 31, 2022 | $253.20M | +30.2% |
| Q1 FY2023 | Sep 30, 2022 | $207.16M | -25.0% |
| Q4 FY2022 | Jun 30, 2022 | $273.71M | -7.3% |
| Q3 FY2022 | Mar 31, 2022 | $201.77M | -12.5% |
| Q2 FY2022 | Dec 31, 2021 | $194.48M | -24.0% |
| Q1 FY2022 | Sep 30, 2021 | $276.15M | -34.5% |
| Q4 FY2021 | Jun 30, 2021 | $295.28M | -36.2% |
| Q3 FY2021 | Mar 31, 2021 | $230.64M | -34.6% |
| Q2 FY2021 | Dec 31, 2020 | $255.87M | +25.4% |
| Q1 FY2021 | Sep 30, 2020 | $421.41M | +144.8% |
| Q4 FY2020 | Jun 30, 2020 | $463.16M | +214.8% |
| Q3 FY2020 | Mar 31, 2020 | $352.86M | +140.8% |
| Q2 FY2020 | Dec 31, 2019 | $204.10M | +36.5% |
| Q1 FY2020 | Sep 30, 2019 | $172.15M | -25.2% |
| Q4 FY2019 | Jun 30, 2019 | $147.13M | -22.0% |
| Q3 FY2019 | Mar 31, 2019 | $146.51M | -79.2% |
| Q2 FY2019 | Dec 31, 2018 | $149.47M | -82.6% |
| Q1 FY2019 | Sep 30, 2018 | $230.19M | -71.6% |
| Q4 FY2018 | Jun 30, 2018 | $188.70M | -77.0% |
| Q3 FY2018 | Mar 31, 2018 | $704.28M | -14.9% |
| Q2 FY2018 | Dec 31, 2017 | $858.90M | +9.0% |
| Q1 FY2018 | Sep 30, 2017 | $811.10M | +3.8% |
| Q4 FY2017 | Jun 30, 2017 | $821.94M | – |
| Q3 FY2017 | Mar 31, 2017 | $827.31M | – |
| Q2 FY2017 | Dec 31, 2016 | $788.15M | – |
| Q1 FY2017 | Sep 30, 2016 | $781.66M | – |